Webinar One Year After EU FMD Compliance, What Issues Need To Be Addressed?

WHEN: Wednesday, April 29, 2020 at 2p.m. GMT.

It’s been one year since the European Union adopted the Falsified Medicines Directive as a means of combatting counterfeiting in the pharmaceutical industry. How effective has the EU FMD been, and how secure is the supply chain now?

In this webinar, OPTEL’s traceability experts weigh in on the issues that still need to be addressed, including the EU FMD’s bookend approach that makes it a race between authentic and counterfeit medicines to make it to the patient first.

The solution can be found in aggregation and multilayer protection, such as serialization, tamper evidence and digital watermarks, technologies that OPTEL has been developing and perfecting for decades.
The webinar will take place 29 April, at 2 p.m. GMT. Join us and learn:

* Overview and rationale of the EU FMD
* How the EU FMD is working so far
* What the EU FMD has improved or solved
* How the Jennason alert manager can help
* What issues the EU FMD hasn’t solved
* How OPTEL can solve these remaining issues

The webinar will include a question and answer period, during which participants will have an opportunity to interact with the three webinar speakers to question or clarify any of the issues surrounding the EU FMD.

Speakers Bios

Ron Watkins

Guillaume Frapsauce, Account Director, OPTEL GROUP

A project and sales engineer for the past 10 years, Guillaume Frapsauce joined OPTEL five years ago to help manufacturers secure their supply chains by implementing track-and-trace solutions.
Guillaume uses his expertise to help clients define their main challenges and to provide them with solutions specifically adapted to their needs; to secure and monitor his clients’ supply chains without compromising production rates and flexibility; and to deploy next-generation tools to create more intelligent supply chains, such as data collection, analysis and artificial intelligence.
Guillaume holds a master of science degree in automatism, control systems, modelling and simulation from Cranfield University, as well as an engineering degree in mechanical systems design from Université de Technologie de Troyes.

Bill Romano

Scott Pugh, Principal, Jennason, LLC

Scott Pugh has been involved with serialization and supply chain traceability efforts since 2007, starting as a lead within a global consulting firm’s secure supply chain practice. Over his career, Scott has supported customers across multiple industries including life sciences/healthcare, consumer goods, electronics and food/beverage. Scott’s engagement experience ranges from initial education and strategy through capability deployment and ongoing operational support.

As a certified technical architect, Scott’s specific area of expertise is rooted in the design, development and implementation of serialization/traceability solutions. Scott has over 10 years of experience as a contributor and globally recognized expert in GS1 supply chain standards.

Jennason also serves as a trusted provider of serialization solutions including the Jennason Serialization Test Tool and the EU FMD Alert Manager.

Scott is based in Minneapolis, MN USA and has a B.S. in Management Information Systems from Miami (OH) University.

Bill Romano

Grant Courtney, Principal Consultant, Be4ward

Grant Courtney is a leading healthcare industry consultant and industry-recognised expert advisor on digital brand protection and product packaging.

During his 24-year career with GlaxoSmithKline, Grant held multiple global roles in strategy and advocacy management, working on a number of large strategic initiatives, including product coding, serialisation, traceability and pack management.

Grant has been a trusted advisor to EFPIA in defining the industry’s advocacy and strategic approach to anti-counterfeiting and product traceability in Europe. He is co-chair of the cross-industry EU FMD Acquisition and Divestment Workgroup, GS1 Healthcare Public Policy group and the GS1 Digital Link Working Group and is also an elected member of the GS1 Global Healthcare Leadership Team.

Grant has earned numerous industry awards, including the Institute for Safe Medication Practices Award for preventing the spread of counterfeits in Nigeria and the Best Pharmacy Initiative – Falsified Medicines Directive anti-counterfeiting model. Accredited by the Chartered Institute of Marketing, Grant has a degree in business studies and a Lean Sigma Green Belt. He is based in the UK.